Concepedia

Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives

M. RAPS, Frans M. Helmerhorst, Kathrin Fleischer, Stella Thomassen, Frits R. Rosendaal, Jan Rosing, Bart E.P.B. Ballieux, Huib van Vliet

Journal of Thrombosis and Haemostasis · 2012 · 86 citations · 27 references

Open access

Concepts

MedicineHematologyObstetricsReproductive EndocrinologyReproductive HealthReproductive MedicineContraceptive SafetyContraceptive Side EffectsGynecologic EndocrinologyHormonal ContraceptionHormonal InfluencesHormone Binding ProteinsHormonal Contraceptive TherapySex Hormone-binding GlobulinThrombotic Risk AssessmentThrombotic Risk ReductionThrombotic Risk Stratification

References

27

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

Hershel Jick, Susan S. Jick, Michael W. Myers et al. · The Lancet · 1995 · 735 citations

Medicine, Endocrinology, Obstetrics +17

Hormonal contraception and risk of venous thromboembolism: national follow-up study

A. L. Svendsen, Carsten Agger · BMJ · 2009 · 708 citations · Full text

Medicine, Gynecology, Obstetrics +13

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

Astrid van Hylckama Vlieg, Frans M. Helmerhorst, Jan P. Vandenbroucke et al. · BMJ · 2009 · 662 citations · Full text

Medicine, Gynecology, Obstetrics +17

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Lars Nielsen, Charlotte Wessel Skovlund, Finn Egil Skjeldestad · BMJ · 2011 · 609 citations · Full text

Medicine, Gynecology, Obstetrics +14

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease

The Lancet · 1995 · 460 citations

Medicine, Obstetrics, Pharmacology +16